Background
==========

We compare immune responses in humans and rhesus for two popular concepts for an AIDS vaccine, DNA priming and MVA boosting vs MVA priming and boosting.

Methods
=======

Identical doses of HIV and SIV Gag-Pol-Env-expressing DNA (3 mg) and MVA (1 × 108 TCID50) vaccines were tested in humans (HVTN 065) (n = 30) and rhesus (Yerkes M11) (n = 8), respectively. Two protocols were used: DNA at weeks 0 and 8, followed by MVA at weeks 16 and 24 (DDMM) or MVA at weeks 0, 8 and 24 (MMM). Assays for T cells (ICS) and anti-Env Ab (ELISA) were conducted at HVTN (human) or Emory Vaccine Center (macaque) labs at one or two weeks post immunizations.

Results
=======

Whereas rhesus had 100% response rates for all parameters, all human response rates were \<80%. In both species, DNA priming resulted in both higher and more CD4-biased T cell responses. Humans had higher CD4 than CD8 response rates (77% vs. 42%) and macaques, greater magnitudes of elicited CD4 than CD8 cells (medians of 1.57% vs 0.19%). In both species, DNA-primed CD4 responses had \>2.4-fold greater breadth than MVA-primed CD4 cells. Interestingly, both species, for both regimens, had similar peak magnitudes (medians of \~0.15% of total CD8 cells) and breadths of responding CD8 T cells (2 out of 5 tested pools in humans and 5 out of 24 pools in macaques). In both species, MVA-only immunizations elicited the highest anti-Env Ab responses. In humans, MMM elicited more frequent responses (75% vs 27%) and in both species, \>2-times higher titer responses than DDMM. Macaques were much more permissive (\~50-times) for Ab responses than humans achieving median titers of \~14 μg per ml for the MMM regimen.

Conclusion
==========

\(i\) DDMM and MMM immunization elicit distinctive patterns of responses and (ii) immune responses in rhesus are only partial predictors for those in humans.
